PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.440.14 (-2.51%)
5.44 - 5.64
4.95 - 8.28
2.1K / 2.4K (Avg.)
-272.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.32%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
8.60%
Positive gross profit growth while VALMT.HE is negative. John Neff would see a clear operational edge over the competitor.
69.00%
Positive EBIT growth while VALMT.HE is negative. John Neff might see a substantial edge in operational management.
69.00%
Positive operating income growth while VALMT.HE is negative. John Neff might view this as a competitive edge in operations.
36.42%
Positive net income growth while VALMT.HE is negative. John Neff might see a big relative performance advantage.
20.00%
Positive EPS growth while VALMT.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
20.00%
Positive diluted EPS growth while VALMT.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
13.68%
Slight or no buybacks while VALMT.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
13.68%
Slight or no buyback while VALMT.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-10.71%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
35.62%
Positive FCF growth while VALMT.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-32.58%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 30.42%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-20.63%
Negative 5Y CAGR while VALMT.HE stands at 46.69%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-1.38%
Negative 3Y CAGR while VALMT.HE stands at 22.64%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
259.95%
10Y OCF/share CAGR under 50% of VALMT.HE's 3568.21%. Michael Burry would worry about a persistent underperformance in cash creation.
117.57%
Below 50% of VALMT.HE's 967.05%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
190.16%
3Y OCF/share CAGR above 1.5x VALMT.HE's 84.48%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
0.00%
Below 50% of VALMT.HE's 150.59%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-33.33%
Negative 5Y net income/share CAGR while VALMT.HE is 275.89%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-40.00%
Negative 3Y CAGR while VALMT.HE is 67.06%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
19.20%
10Y equity/share CAGR 1.25-1.5x VALMT.HE's 14.49%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
24.65%
5Y equity/share CAGR at 75-90% of VALMT.HE's 27.55%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
18.48%
3Y equity/share CAGR similar to VALMT.HE's 19.81%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
-100.00%
Cut dividends over 10 years while VALMT.HE stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.35%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-6.98%
Inventory is declining while VALMT.HE stands at 6.23%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.79%
Negative asset growth while VALMT.HE invests at 0.61%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-13.40%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.07%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-14.50%
We cut SG&A while VALMT.HE invests at 63.04%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.